Prediction of severe bleeding after coronary surgery: the WILL-BLEED Risk Score

Summary

Severe perioperative bleeding after coronary artery bypass grafting (CABG) is associated with poor outcome. An additive score for prediction of severe bleeding was derived (n=2494) and validated (n=1250) in patients from the E-CABG registry. Severe bleeding was defined as E-CABG bleeding grades 2–3 (transfusion of >4 units of red blood cells or reoperation for bleeding). The overall incidence of severe bleeding was 6.4 %. Preoperative anaemia (3 points), female gender (2 points), eGFR <45 ml/min/1.73 m2 (3 points), potent antiplatelet drugs discontinued less than five days (2 points), critical preoperative state (5 points), acute coronary syndrome (2 points), use of low-molecular-weight heparin/fondaparinux/unfractionated heparin (1 point) were independent predictors of severe bleeding. The WILL-BLEED score was associated with increasing rates of severe bleeding in both the derivation and validation cohorts (scores 0–3: 2.9 % vs 3.4 %; scores 4–6: 6.8 % vs 7.5 %; scores>6: 24.6 % vs 24.2 %, both p<0.0001). The WILL-BLEED score had a better discriminatory ability (AUC 0.725) for prediction of severe bleeding compared to the ACTION (AUC 0.671), CRUSADE (AUC 0.642), Papworth (AUC 0.605), TRUST (AUC 0.660) and TRACK (AUC 0.640) bleeding scores. The net reclassification index and integrated discrimination improvement using the WILL-BLEED score as opposed to the other bleeding scores were significant (p<0.0001). The decision curve analysis demonstrated a net benefit with the WILL-BLEED score compared to the other bleeding scores. In conclusion, the WILL-BLEED risk score is a simple risk stratification method which allows the identification of patients at high risk of severe bleeding after CABG.

Clinical Trial Registration: NCT02319083 (https://clinicaltrials.gov/ct2/show/NCT02319083)

Keywords

Bleeding - coronary artery bypass grafting - CABG - cardiac surgery - risk score

• References

• 1 Habib RH, Zacharias A, Schwann TA. et al. Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: should current practice be changed? J Thorac Cardiovasc Surg. 2003; 125: 1438-1450.
• 2 Eikelboom JW, Mehta SR, Anand SS. et al. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 2006; 114: 774-782.
• 3 Rao SV, O’Grady K, Pieper KS. et al. Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol 2005; 96: 1200-1206.
• 4 Manoukian SV, Feit F, Mehran R. et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes. An analysis from the ACUITY trial J Am Coll Cardiol 2007; 49: 1362-1368.
• 5 Mehta SK, Frutkin AD, Lindsey JB. et al. Bleeding in patients undergoing percutaneous coronary interv-ention: the development of a clinical risk algorithm from the national cardiovascular data registry. Circ Cardiovasc Interv 2009; 02: 222-229.
• 6 Mehran R, Pocock SJ, Nikolsky E. et al. A risk score to predict bleeding in patients with acute coronary syndromes. J Am Coll Cardiol 2010; 55: 2556-2566.
• 7 Subherwal S, Bach RG, Chen AY. et al. Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction. The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) bleeding score Circulation 2009; 119: 1873-1882.
• 8 Mathews R, Peterson ED, Chen AY. et al. In-hospital major bleeding during ST-elevation and non-ST-elevation myocardial infarction care: derivation and validation of a model from the ACTION Registry®-GWTG™. Am J Cardiol 2011; 107: 1136-1143.
• 9 Vuylsteke A, Pagel C, Gerrard C. et al. The Papworth Bleeding Risk Score: a stratification scheme for identifying cardiac surgery patients at risk of excessive early postoperative bleeding. Eur J Cardiothorac Surg 2011; 39: 924-931.
• 10 Alghamdi AA, Davis A, Brister S. et al. Development and validation of Transfusion Risk Understanding Scoring Tool (TRUST) to stratify cardiac surgery patients according to their blood transfusion needs. Transfusion 2006; 46: 1120-1129.
• 11 Ranucci M, Castelvecchio S, Frigiola A. et al. Predicting transfusions in cardiac surgery: the easier, the better: the Transfusion Risk and Clinical Knowledge score. Vox Sang 2009; 96: 324-332.
• 12 Biancari F, Ruggieri VG, Perrotti A. et al. European multicentre study on coronary artery bypass grafting (E-CABG registry): study protocol for a prospective clinical registry and proposal of classification of postoperative complications. J Cardiothorac Surg 2015; 10: 90.
• 13 Hansson EC, Jidéus L, Åberg B. et al. Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study. Eur Heart J 2016; 37: 189-197.
• 14 Schneeweiss S, Wang PS, Avorn J. et al. Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Serv Res 2003; 38: 1103-1120.
• 15 Youden WJ.. Index for rating diagnostic tests. Cancer 1950; 03: 32-35.
• 16 DeLong ER, DeLong DM, Clarke-Pearson DL.. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-845.
• 17 Hosmer DW, Lemeshow S.. A goodness-of-fitness test for the multiple logistic regression model. Comm Stat 1980; A 10: 1043-1069.
• 18 Pencina MJ, D’Agostino Sr RB, D’Agostino Jr RB, Vasan RS.. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157-172.
• 19 Vickers AJ, Elkin EB.. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 2006; 26: 565-574.
• 20 Bhatt DL, Hulot JS, Moliterno DJ. et al. Antiplatelet and anticoagulation therapy for acute coronary syndromes. Circ Res 2014; 114: 1929-1943.
• 21 Vasques F, Kinnunen EM, Pol M. et al. Outcome of Jehovah’s Witnesses after adult cardiac surgery: systematic review and meta-analysis of comparative studies. Transfusion 2016; 56: 2146-2153.
• 22 D’Ambra MN, FitzGerald D, Kaufman RM. et al. Blood conservation: why aren’t we doing this for everyone? J Thorac Cardiovasc Surg. 2015; 150: 984-985.
• 23 Deppe AC, Weber C, Zimmermann J. et al. Point-of-care thromboelastography/thromboelastometry-based coagulation management in cardiac surgery: a meta-analysis of 8332 patients. J Surg Res 2016; 203: 424-433.
• 24 Biancari F, Mikkola R, Heikkinen J. et al. Individual surgeon’s impact on the risk of re-exploration for excessive bleeding after coronary artery bypass surgery. J Cardiothorac Vasc Anesth 2012; 26: 550-556.
• 25 Vonk AB, Meesters MI, Garnier RP. et al. Intraoperative cell salvage is associated with reduced postoperative blood loss and transfusion requirements in cardiac surgery: a cohort study. Transfusion 2013; 53: 2782-2789.
• 26 Ranucci M, Baryshnikova E, Crapelli GB. et al. Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. J Am Heart Assoc 2015; 04: e002066.
• 27 Ortmann E, Besser MW, Sharples LD. et al. An exploratory cohort study comparing prothrombin complex concentrate and fresh frozen plasma for the treatment of coagulopathy after complex cardiac surgery. Anesth Analg 2015; 121: 26-33.
• 28 Kinnunen EM, Mosorin MA, Perrotti A. et al. Validation of a new classification method of postoperative complications in patients undergoing coronary artery surgery. J Cardiothorac Vasc Anesth 2016; 30: 330-337.
• 29 Rao SV, McCoy LA, Spertus JA. et al. An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention: a report using an expanded bleeding definition from the National Cardiovascular Data Registry CathPCI Registry. JACC Cardiovasc Interv 2013; 06: 897-904.
• 30 Du VX, Huskens D, Maas C. et al. New insights into the role of erythrocytes in thrombus formation. Semin Thromb Hemost 2014; 40: 72-80.
• 31 Acedillo RR, Shah M, Devereaux PJ. et al. The risk of perioperative bleeding in patients with chronic kidney disease: a systematic review and meta-analysis. Ann Surg 2013; 258: 901-913.
• 32 Lutz J, Menke J, Sollinger D. et al. Haemostasis in chronic kidney disease. Nephrol Dial Transplant 2014; 29: 29-40.
• 33 Ahmed B, Dauerman HL.. Women, bleeding, and coronary intervention. Circulation 2013; 127: 641-649.
• 34 Davidson S.. State of the art - how I manage coagulopathy in cardiac surgery patients. Br J Haematol 2014; 164: 779-789.
• 35 Biancari F, Mikkola R, Heikkinen J. et al. Estimating the risk of complications related to re-exploration for bleeding after adult cardiac surgery: a systematic review and meta-analysis. Eur J Cardiothorac Surg 2012; 41: 50-55.
• 36 Karkouti K, Callum J, Wijeysundera DN. et al. Point-of-care hemostatic testing in cardiac surgery: a stepped-wedge clustered randomized controlled trial. Circulation 2016. in press.